BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24889893)

  • 1. Effect of tablets containing probiotic bacteria (Lactobacillus reuteri) on early caries lesions in adolescents: a pilot study.
    Keller MK; Nøhr Larsen I; Karlsson I; Twetman S
    Benef Microbes; 2014 Dec; 5(4):403-7. PubMed ID: 24889893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of orally administered probiotic Lactobacillus reuteri-containing tablets in peri-implant mucositis: a double-blind randomized controlled trial.
    Flichy-Fernández AJ; Ata-Ali J; Alegre-Domingo T; Candel-Martí E; Ata-Ali F; Palacio JR; Peñarrocha-Diago M
    J Periodontal Res; 2015 Dec; 50(6):775-85. PubMed ID: 25712760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of
    Borrell García C; Ribelles Llop M; García Esparza MÁ; Flichy-Fernández AJ; Marqués Martínez L; Izquierdo Fort R
    Int J Immunopathol Pharmacol; 2021; 35():20587384211031107. PubMed ID: 34325540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of probiotic bacteria as dental caries and periodontal disease biotherapeutics.
    Saha S; Tomaro-Duchesneau C; Rodes L; Malhotra M; Tabrizian M; Prakash S
    Benef Microbes; 2014 Dec; 5(4):447-60. PubMed ID: 25006013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotic effects of orally administered Lactobacillus reuteri-containing tablets on the subgingival and salivary microbiota in patients with gingivitis. A randomized clinical trial.
    Iniesta M; Herrera D; Montero E; Zurbriggen M; Matos AR; Marín MJ; Sánchez-Beltrán MC; Llama-Palacio A; Sanz M
    J Clin Periodontol; 2012 Aug; 39(8):736-44. PubMed ID: 22694350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread.
    Dommels YE; Kemperman RA; Zebregs YE; Draaisma RB; Jol A; Wolvers DA; Vaughan EE; Albers R
    Appl Environ Microbiol; 2009 Oct; 75(19):6198-204. PubMed ID: 19684171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the probiotic bacterium Lactobacillus reuteri on white spot lesion development in orthodontic patients.
    Gizani S; Petsi G; Twetman S; Caroni C; Makou M; Papagianoulis L
    Eur J Orthod; 2016 Feb; 38(1):85-89. PubMed ID: 25840585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of drops containing Lactobacillus reuteri (DSM 17938 and ATCC PTA 5289) on plaque acidogenicity and other caries-related variables in orthodontic patients.
    Alforaidi S; Bresin A; Almosa N; Lehrkinder A; Lingström P
    BMC Microbiol; 2021 Oct; 21(1):271. PubMed ID: 34615458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary mutans streptococci and lactobacilli levels after ingestion of the probiotic bacterium Lactobacillus reuteri ATCC 55730 by straws or tablets.
    Caglar E; Cildir SK; Ergeneli S; Sandalli N; Twetman S
    Acta Odontol Scand; 2006 Oct; 64(5):314-8. PubMed ID: 16945898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of
    Wälivaara DÅ; Sjögren I; Gerasimcik N; Yucel-Lindberg T; Twetman S; Abrahamsson P
    Benef Microbes; 2019 Jul; 10(6):653-659. PubMed ID: 31157556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiological profiles in saliva and supragingival plaque from caries-active adolescents before and after a short-term daily intake of milk supplemented with probiotic bacteria - a pilot study.
    Lexner MO; Blomqvist S; Dahlén G; Twetman S
    Oral Health Prev Dent; 2010; 8(4):383-8. PubMed ID: 21180676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of Lactobacillus reuteri during the first year of life reduces caries prevalence in the primary dentition at 9 years of age.
    Stensson M; Koch G; Coric S; Abrahamsson TR; Jenmalm MC; Birkhed D; Wendt LK
    Caries Res; 2014; 48(2):111-7. PubMed ID: 24296746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of Lactobacillus reuteri in saliva coincide with higher salivary IgA in young adults after intake of probiotic lozenges.
    Braathen G; Ingildsen V; Twetman S; Ericson D; Jørgensen MR
    Benef Microbes; 2017 Feb; 8(1):17-22. PubMed ID: 27873545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of probiotic chewing tablets on early childhood caries--a randomized controlled trial.
    Hedayati-Hajikand T; Lundberg U; Eldh C; Twetman S
    BMC Oral Health; 2015 Sep; 15(1):112. PubMed ID: 26403472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel delivery system of probiotic drop and its effect on dental caries risk factors in cleft lip/palate children.
    Cildir SK; Sandalli N; Nazli S; Alp F; Caglar E
    Cleft Palate Craniofac J; 2012 May; 49(3):369-72. PubMed ID: 21309653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of probiotic lozenges containing Lactobacillus reuteri on oral wound healing: a pilot study.
    Twetman S; Keller MK; Lee L; Yucel-Lindberg T; Pedersen AML
    Benef Microbes; 2018 Sep; 9(5):691-696. PubMed ID: 29726282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid production in dental plaque after exposure to probiotic bacteria.
    Keller MK; Twetman S
    BMC Oral Health; 2012 Oct; 12():44. PubMed ID: 23092239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Lactobacillus reuteri DSM 17938 for the Prevention of Nosocomial Diarrhea in Children: A Randomized, Double-blind, Placebo-controlled Trial.
    Urbańska M; Gieruszczak-Białek D; Szymański H; Szajewska H
    Pediatr Infect Dis J; 2016 Feb; 35(2):142-5. PubMed ID: 26551445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of Lactobacillus Reuteri DSM 17938 in Healthy Children 2-5 Years of Age.
    Kosek MN; Peñataro-Yori P; Paredes-Olortegui M; Lefante J; Ramal-Asayag C; Zamora-Babilonia M; Meza-Sanchez G; Oberhelman RA
    Pediatr Infect Dis J; 2019 Aug; 38(8):e178-e180. PubMed ID: 30531312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactobacillus reuteri supplements do not affect salivary IgA or cytokine levels in healthy subjects: A randomized, double-blind, placebo-controlled, cross-over trial.
    Jørgensen MR; Keller MK; Kragelund C; Hamberg K; Ericson D; Nielsen CH; Twetman S
    Acta Odontol Scand; 2016 Jul; 74(5):399-404. PubMed ID: 27104984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.